T1	Participants 431 560	20 patients receiving flecainide, 14 of 17 (82%) with AF converted to sinus rhythm, but in 3 patients with AFI flecainide failed.
T2	Participants 270 347	40 patients with paroxysmal atrial fibrillation (AF) or atrial flutter (AFI).
